ZT002 Placebo

DRUG2 trials

Sponsors

Beijing QL Biopharmaceutical Co.,Ltd

Conditions

Overweight or ObesityType 2 Diabetes

Phase 1

A Study of ZT002 Injection in Adult Chinese Subjects With Type 2 Diabetes Mellitus (T2DM)

CompletedNCT07065032

Beijing QL Biopharmaceutical Co.,LtdType 2 Diabetes

Start: 2024-02-19End: 2024-08-05Updated: 2025-07-15

Phase 2

A Study of ZT002 Injection With Subjects With Overweight or Obesity

CompletedNCT07020884

Beijing QL Biopharmaceutical Co.,LtdOverweight or Obesity

Start: 2024-08-14End: 2025-05-29Updated: 2025-12-10